X
Xvivo perfusion
Biotech & Life Sciences · Göteborgs Stad, Sweden · Founded 1998 · IPO 2012 Unicorn
Global footprint
Where Xvivo perfusion has talent and traffic
team presence
Patent intelligence
$15M patent portfolio · 8 active families
Where Xvivo perfusion concentrates vs peers
Each axis is a top-10 topic across Xvivo perfusion and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Xvivo perfusion's 3 investments and acquisitions.
Every disclosed deal where Xvivo perfusion appeared as a backer or acquirer, 2020–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Xvivo perfusion's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Xvivo perfusion deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Xvivo perfusion's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Xvivo perfusion
An AI-synthesized read of the highest-engagement posts about Xvivo perfusion on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xvivo perfusion on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.